Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Cohen, Eran ^a   Avrahami, Dana ^a   Frid, Kati ^a   Canello, Tamar ^a   Levy Lahad, Ephrat ^b,c   Zeligson, Sharon ^b,c   Perlberg, Shira ^b,c   Chapman, Joab ^d   Cohen, Oren S ^d   Kahana, Esther ^e   Lavon, Iris ^a   Gabizon, Ruth ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e BARZILAI MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; COPPER; MESSENGER RNA; MOLECULAR MARKER; SNORD 3A; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EMBRYO; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; FEMALE; HETEROZYGOTE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PROTEIN EXPRESSION; RNA TRANSCRIPTION; SCRAPIE; UNFOLDED PROTEIN RESPONSE;

ACTIVATING TRANSCRIPTION FACTOR 6; ANIMALS; BIOLOGICAL MARKERS; BRAIN; COPPER; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM STRESS; HETEROZYGOTE; HUMANS; MICE; PRION DISEASES; PRIONS; PRPC PROTEINS; RNA, SMALL NUCLEOLAR; RNA, UNTRANSLATED;

MUS;

EID: 84872665858     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054433     Document Type: Article

References (45)

1. DeArmond SJ, Bouzamondo E, (2002) Fundamentals of prion biology and diseases. Toxicology 181-182: 9-16.
2. Prusiner SB, (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
3. Olanow CW, Prusiner SB, (2009) Is Parkinson's disease a prion disorder? Proc Natl Acad Sci U S A 106: 12571-12572.
4. Frost B, Diamond MI, (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11: 155-159.
5. Jucker M, Walker LC, (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70: 532-540.
6. Hamacher M, Meyer HE, Marcus K, (2007) New access to Alzheimer's and other neurodegenerative diseases. Expert Rev Proteomics 4: 591-594.
7. Saborio GP, Permanne B, Soto C, (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813.
8. Spudich S, Mastrianni JA, Wrensch M, Gabizon R, Meiner Z, et al. (1995) Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1: 607-613.
9. Meiner Z, Gabizon R, Prusiner SB, (1997) Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews. Medicine (Baltimore) 76: 227-237.
10. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG, (2006) Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91: 221-230.
11. Kahana E AM, Braham J, Sofer D, (1974) Creutzfeldt-jakob disease: focus among Libyan Jews in Israel. Science Jan 11: 90-91.
12. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, et al. (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 324: 1091-1097.
13. Chapman J, Brown P, Goldfarb LG, Arlazoroff A, Gajdusek DC, et al. (1993) Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 56: 1109-1112.
14. Lee HS, Sambuughin N, Cervenakova L, Chapman J, Pocchiari M, et al. (1999) Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. Am J Hum Genet 64: 1063-1070.
15. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG, (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66: 213-239.
16. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, et al. (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224-233.
17. Dalma-Weiszhausz DD, Chicurel ME, Gingeras TR, (2002) Microarrays and genetic epidemiology: a multipurpose tool for a multifaceted field. Genet Epidemiol 23: 4-20.
18. Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, et al. (2005) Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann N Y Acad Sci 1053: 356-375.
19. Friedman-Levi Y, Meiner Z, Canello T, Frid K, Kovacs GG,et al. Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease. PLoS Pathog 7: e1002350.
20. Esteller M, (2011) Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
21. Hetz C, (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13: 89-102.
22. Lipshutz RJ, Morris D, Chee M, Hubbell E, Kozal MJ, et al. (1995) Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19: 442-447.
23. Watkins NJ, Lemm I, Ingelfinger D, Schneider C, Hossbach M, et al. (2004) Assembly and maturation of the U3 snoRNP in the nucleoplasm in a large dynamic multiprotein complex. Mol Cell 16: 789-798.
24. Kishore S, Stamm S, (2006) The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311: 230-232.
25. Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, et al. (2011) Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab 14: 33-44.
26. Kong D, Kotraiah V, (2012) Modulation of Aldehyde Dehydrogenase Activity Affects (+/-)-4-Hydroxy-2E-nonenal (HNE) Toxicity and HNE-Protein Adduct Levels in PC12 Cells. J Mol Neurosci 47: 595-603.
27. Zhang M, Shoeb M, Goswamy J, Liu P, Xiao TL, et al. (2012) Overexpression of aldehyde dehydrogenase 1A1 reduces oxidation-induced toxicity in SH-SY5Y neuroblastoma cells. J Neurosci Res 88: 686-694.
28. Freixes M, Rodriguez A, Dalfo E, Ferrer I, (2006) Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging 27: 1807-1815.
29. Arlt S, Kontush A, Zerr I, Buhmann C, Jacobi C, et al. (2002) Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease. Neurobiol Dis 10: 150-156.
30. Canello T, Frid K, Gabizon R, Lisa S, Friedler A, et al. (2010) Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP. PLoS Pathog 6: e1000977.
31. Xu J (2005) Preparation, culture, and immortalization of mouse embryonic fibroblasts. Curr Protoc Mol Biol Chapter 28: Unit 28 21.
32. Canello T, Friedman-Levi Y, Mizrahi M, Binyamin O, Cohen E, et al. (2012) Copper is toxic to PrP-ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease. Neurobiol Dis 45: 1010-1017.
33. Avrahami D, Gabizon R, (2011) Age-related alterations affect the susceptibility of mice to prion infection. Neurobiol Aging 32: 2006-2015.
34. Xiang W, Windl O, Wunsch G, Dugas M, Kohlmann A, et al. (2004) Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol 78: 11051-11060.
35. Riemer C, Neidhold S, Burwinkel M, Schwarz A, Schultz J, et al. (2004) Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun 323: 556-564.
36. Turner BJ, Parkinson NJ, Davies KE, Talbot K, (2009) Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiol Dis 34: 511-517.
37. Doyle KM, Kennedy D, Gorman AM, Gupta S, Healy SJ, et al. (2012) Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J Cell Mol Med 15: 2025-2039.
38. Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, et al. (2012) Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485: 507-511.
39. Quaglio E, Restelli E, Garofoli A, Dossena S, De Luigi A, et al. (2011) Expression of mutant or cytosolic PrP in transgenic mice and cells is not associated with endoplasmic reticulum stress or proteasome dysfunction. PLoS One 6: e19339.
40. Yoshida H, Haze K, Yanagi H, Yura T, Mori K, (1998) Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem 273: 33741-33749.
41. Baserga SJ, Yang XD, Steitz JA, (1991) An intact Box C sequence in the U3 snRNA is required for binding of fibrillarin, the protein common to the major family of nucleolar snRNPs. EMBO J 10: 2645-2651.
42. Wehner KA, Ayala L, Kim Y, Young PJ, Hosler BA, et al. (2002) Survival motor neuron protein in the nucleolus of mammalian neurons. Brain Res 945: 160-173.
43. Sultana R, Butterfield DA, (2009) Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease. Methods Mol Biol 566: 123-135.
44. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W, (2012) Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease. Neurodegener Dis 10: 212-215.
45. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577-582.